Edith M. Lord, Ph.D.

Edith M. Lord, Ph.D.

Contact Information

University of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 316
Rochester, NY 14642

Professional Bio

Dr. Edith Lord is the Senior Associate Dean for Graduate Education and Postdoctoral Affairs at the School of Medicine and Dentistry. Dr. Lord received her BA degree in microbiology from the University of Kansas in 1970 and a Ph.D degree in immunology from the University of California at San Diego in 1975. She was a postdoctoral fellow at the University of California at San Francisco. Dr. Lord leads the School of Medicine and Dentistry's Ph.D., postdoctoral and master's degree programs. As a faculty member since 1976, Dr. Lord has demonstrated excellence as a scientist and dedication to her position as Senior Associate Dean.



From 2006-2008, Dr. Lord led the graduate program in the Department of Microbiology and Immunology. She also directs the school's Post-baccalaureate Research and Education Program (PREP), which encourages underrepresented minorities to pursue a research doctorate and prepares them for careers as scientists and leaders in the biomedical community.

In her research, Dr. Lord focuses on the immune responses that can control tumor development and also studies the unique microenvironment present within growing tumors. She has published, as author and co-author, more than 100 scientific articles and continues her passion for research today.

Patents

Monoclonal Antibodies Differentially Reactive with Native and Reductively Modified Bowman-Birk Protease Inhibitor

United States Serial NO.: 08/458,353
Filed Date: June 2, 1995
Title: Monoclonal Antibodies Differentially Reactive with Native and Reductively Modified Bowman-Birk Protease Inhibitor
Invented by: Edith Lord, Ann Kennedy, Cameron Koch, Xingsheng Wan
Monoclonal Antibodies Differentially Reactive with Native and Reductively Modified Bowman-Birk Protease Inhibitor

United States Serial NO.: 08/358,265
Filed Date: December 19, 1994
Title: Method of Monitoring Exposure to Bowman Birk Inhibitor Using Monoclonal Antibodies Against Bowman Birk Inhibitor Metabolites
Invented by: Edith Lord, Ann Kennedy, Cameron Koch, Xingsheng Wan
Detection of Hypoxia

United States Serial NO.: 08/286,065
Filed Date: August 4, 1994
Title: Detection of Hypoxia with Reagents Containing 2-Nitroimidazole Compounds and Methods of Making such Reagents.
Invented by: Edith Lord, Cameron Koch
Detection of Hypoxia

United States Serial NO.: 08/598,752
Filed Date: February 8, 1996
Title: Detection of Hypoxia
Invented by: Edith Lord, Cameron Koch
Human Glandular Kallikrein (hK2)-Specific Monoclonal Antibodies that Enhance or Inhibit the Enzymatic Activity of hK2

United States Serial NO.: 10/491,761
Filed Date: October 3, 2002
Title: Human Glandular Kallikrein (HK2)-Specific Monoclonal Antibodies that Enhance or Inhibit the Enzymatic Activity of HK2
Invented by: John Frelinger, Terrence Fisher, Mary Ann Nocera-March, Edith Lord

Recent Journal Articles

Showing the 5 most recent journal articles. 60 available »

2014 May 15
Gerber SA, Lim JY, Connolly KA, Sedlacek AL, Barlow ML, Murphy SP, Egilmez NK, Lord EM. "Radio-responsive tumors exhibit greater intratumoral immune activity than nonresponsive tumors." International journal of cancer. Journal international du cancer. 2014 May 15; 134(10):2383-92. Epub 2013 Nov 11.
2014 Apr 14
Xu Y, Hyun YM, Lim K, Lee H, Cummings RJ, Gerber SA, Bae S, Cho TY, Lord EM, Kim M. "Optogenetic control of chemokine receptor signal and T-cell migration." Proceedings of the National Academy of Sciences of the United States of America.. 2014 Apr 14; Epub 2014 Apr 14.
2013 Oct
Sedlacek AL, Gerber SA, Randall TD, van Rooijen N, Frelinger JG, Lord EM. "Generation of a dual-functioning antitumor immune response in the peritoneal cavity." The American journal of pathology.. 2013 Oct; 183(4):1318-28. Epub 2013 Aug 08.
2011 Oct 28
Valentino MD, Abdul-Alim CS, Maben ZJ, Skrombolas D, Hensley LL, Kawula TH, Dziejman M, Lord EM, Frelinger JA, Frelinger JG. "A broadly applicable approach to T cell epitope identification: application to improving tumor associated epitopes and identifying epitopes in complex pathogens." Journal of immunological methods. 2011 Oct 28; 373(1-2):111-26. Epub 2011 Aug 18.
2010 Feb 15
Sorensen EW, Gerber SA, Frelinger JG, Lord EM. "IL-12 suppresses vascular endothelial growth factor receptor 3 expression on tumor vessels by two distinct IFN-gamma-dependent mechanisms." The Journal of immunology : official journal of the American Association of Immunologists.. 2010 Feb 15; 184(4):1858-66. Epub 2010 Jan 08.

Current Appointments

Senior Associate Dean, Graduate Education - Department of Dean's Office M&D - Administration (SMD)
Professor - Department of Microbiology and Immunology (SMD) - Primary
Professor - Cancer Center

Education

PhD | Immunology | Univ of Cal San Diego1975
BA | Microbiology | University of Kansas1970